Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Non Operating Income (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Non Operating Income for 10 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 68.77% year-over-year to -$1.2 million, compared with a TTM value of -$1.2 million through Dec 2025, down 2.48%, and an annual FY2025 reading of -$1.2 million, down 80.86% over the prior year.
  • Non Operating Income was -$1.2 million for Q4 2025 at Abvc Biopharma, down from $261922.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $647742.0 in Q4 2021 and bottomed at -$1.2 million in Q3 2023.
  • Average Non Operating Income over 5 years is -$165527.3, with a median of -$35342.0 recorded in 2022.
  • The sharpest move saw Non Operating Income plummeted 44149.71% in 2021, then skyrocketed 62208.45% in 2022.
  • Year by year, Non Operating Income stood at $647742.0 in 2021, then tumbled by 136.05% to -$233488.0 in 2022, then soared by 101.95% to $4558.0 in 2023, then crashed by 15674.29% to -$709876.0 in 2024, then crashed by 68.77% to -$1.2 million in 2025.
  • Business Quant data shows Non Operating Income for ABVC at -$1.2 million in Q4 2025, $261922.0 in Q3 2025, and -$14223.0 in Q2 2025.